Trial intelligence / Profile preview

Pharmacokinetic Study of DSP-1958 (Thiotepa)

jRCT2080223378Phase 1

Sponsor
Sumitomo Pharma
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of thiotepa in hematopoietic malignancies, sponsored by Sumitomo Pharma. Primary endpoint: Primary pharmacokinetic endpoints.

02

Drugs

thiotepa
03

Conditions

hematopoietic malignancies

Beyond the preview

Go deeper on jRCT2080223378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call